Karen Narolewski Engel Investor
Experienced Vice President Operations with a background in finance, legal analysis, and financial analysis in the healthcare industry. Skilled in creating value for portfolio companies and working with management teams to drive success. Holds an MBA from La Salle University and a BA in Political Science from Bloomsburg University of Pennsylvania. Currently leading operations at SR One Capital Management, the corporate venture capital arm of GlaxoSmithKline. Proven track record of investing over $680MM in the biotech space. Passionate about innovative science and its impact on medical care.
Headquarters:
United States of America